Vaccine Development
This article considers ethical considerations surrounding pediatric vaccine development for pandemic preparedness, examines some historical cases of pediatric vaccines developed during past smallpox, influenza, and 2019 coronavirus disease pandemics, and discusses the current state of vaccine development for pandemic preparedness, including vaccines against smallpox/mpox, influenza, anthrax, and Ebola that are included in the US Strategic National Stockpile and vaccines being developed against priority pathogens identified by the World Health Organization.
Source: Pediatric Clinics of North America - Category: Pediatrics Authors: Elizabeth A.D. Hammershaimb, James D. Campbell Source Type: research
More News: Anthrax | Anthrax Vaccine | Coronavirus | Covid Vaccine | COVID-19 | Ebola | Ebola Vaccine | Flu Pandemic | History of Medicine | Influenza | Influenza Vaccine | International Medicine & Public Health | Medical Ethics | Pandemics | Pediatrics | Smallpox | Smallpox Vaccine | Vaccines | WHO